---
$id: https://graph.org.ai/products/commodity/51143203
$type: Product
source: UNSPSC
code: "51143203"
title: "Varenicline"
class: "51143200"
classTitle: "Anti abuse drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Varenicline

**UNSPSC Code**: 51143203
**Class**: [Anti abuse drugs](Anti abuse drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic agonist with the molecular formula C13H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W6HS99O8ZO, chemically known as 7,8,9,10-tetrahydro-6,10-methano-6h-pyrazino(2,3-h)(3)benzazepine but generally known as varenicline, which bears US NIH Compound Identifier 170361. European Medicines Agency schedules Varenicline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25195. World Health Organization schedules varenicline in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule varenicline under HS 29333999 and SITC 51574. As of Q4 2014, VARENICLINE remains the US FDA Preferred Term for this commodity. Varenicline bears US NLM identifiers UMLS ID C1569608 and NCI Concept Code C73609. SMILES: N1CC2CC(C3C2CC2NCCNC2C3)C1.

